Quest Diagnostics to Acquire Celera - WSJ.com
Links shared publicly online about this topic.
- 423total visits
Quest Diagnostics to Acquire Celera - WSJ.com
View full resource at online.wsj.com
Tags: Medical
Most Recently Shared on March 21, 2011 at 3:44 pm By:
Quest Diagnostics to Acquire Celera http://on.wsj.com/i3cvjd #diagnostic
S.E.D. Labs to be Acquired by Quest Diagnostics | IVD Technology
ivdtechnology.com — “S.E.D. Medical Laboratories will soon become part of Quest Diagnostics Inc. through a definitive agreement signed by Lovelace Health System and Quest Diagnostics. According to the agreement, Quest Diagnostics will acquire the assets of S.E.D. Medical Laboratories and manage in-patient labs for the four Lovelace hospitals, as well as serve Lovelace Health Plan members. Financial terms of the transaction, which is expected to be completed this month, were not disclosed.” View full resource at ivdtechnology.com
Most Recently Shared on January 3, 2012 at 9:21 pm By:
IVD Technology Health Magazine
S.E.D. Labs to be Acquired by Quest Diagnostics http://t.co/H3TMCPCp
Quest Diagnostics enters definitive merger agreement to acquire Celera for $8 per share
news-medical.net — “Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, and Celera Corporation, one of the world's pioneers in genetic diagnostics discovery and development, announced today that they have entered into a definitive merger agreement under which Quest Diagnostics will acquire Celera for $8 per share, representing a transaction value of approximately $344 million, net of $327 million in acquired cash and short-term investments.” View full resource at news-medical.net
Most Recently Shared on March 18, 2011 at 1:52 pm By:
Genetics News: Quest Diagnostics enters definitive merger agreement to acquire Celera for $8 per share: Quest Di... http://bit.ly/gkbmHz
GSK Announces Sale of Entire Shareholding in Quest Diagnostics | IVD Technology
ivdtechnology.com — “GlaxoSmithKline plc has sold its entire holding of 30,755,151 shares of common stock in Quest Diagnostics Inc.. The sale comprised a secondary public offering by GSK and an accompanying repurchase of shares by Quest. GSK originally acquired the shareholding as partial consideration for the sale of its clinical laboratories business in 1999 and has since gradually reduced its stake in stages.” View full resource at ivdtechnology.com
Most Recently Shared on February 2, 2011 at 6:52 pm By:
IVD Technology Health Magazine
GSK Announces Sale of Entire Shareholding in Quest Diagnostics http://tinyurl.com/62wr7s2
Advertisement
